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Stimulation of tumour angiogenesis by proximal
wounds: spatial and temporal analysis by MRI
R Abramovitch, M Marikovsky, G Meir and M Neeman
Department of Biological Regulation, The Weizmann Institute of Science, Rehovot 76100, Israel
Summary We show here, using high-resolution magnetic resonance imaging, that injured tissue provides a favourable milieu for the
neovascularization and growth of C6 glioma spheroids, implanted subcutaneously in nude mice. Moreover, the presence of micro-tumours in
an injured tissue inhibited the healing process, leaving an open persistent wound. In correlation with the induced angiogenesis of implanted
spheroids in the presence of proximal wounds, a shorter lag period was observed for initiation of tumour growth. This effect was restricted
spatially and was observed only for wounds within 5 mm from the tumour. In such proximal wounds, angiogenesis was enhanced in the first
days after injury, and vessel regression, which normally starts 4 days after injury, did not occur. Injury causing interference to tumourperfusion
promoted tumour vascularization and growth even for more remote incisions, possibly byactivating stress-induced angiogenesis. The kinetics
of vascularization and growth of these wound-tumour systems sheds light on the clinical observations of increased probability of metastatic
recurrence and stimulated regrowth of residual tumour in the site of surgical intervention. High-resolution magnetic resonance imaging could
detect the aberrant angiogenic activity of these tumour-wound systems as early as 1 week after injury.
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The induction of growth of blood vessels towards an avascular
micro-tumour marks a critical check point in the progression of
solid tumours (Sutherland, 1988; Folkman and Shing, 1992;
Folkman, 1995). Avascular tumours are limited to approximately
2 mm in diameter and, beyond this size, tumour growth is depen-
dent on angiogenesis. The accelerated progression of tumours
located on sites of tissue injury is a recognized clinical phenom-
enon (Murthy et al, 1989; Schackert and Fidler, 1989). The focus
of this work was to determine the contribution of the angiogenic
activity associated with wound healing to this phenomenon.
The concept that injuries promote tumour development at the
injured site, in mice that were exposed to carcinogens, has already
been suggested by Deelman (1927) and was later expanded to
exposure to X-ray irradiation (Haran-Ghera et al, 1962), chemical
(Fisher et al, 1967; Orr et al, 1986), mechanical (Fisher et al, 1967;
Sugarbaker et al, 1971) or surgical (Paschkis et al, 1955; Fisher et
al, 1967; Schackert and Fidler, 1989) trauma. Trauma increased
the probability of tumour formation in the injured organ, without
affecting the distribution to other sites, by promoting implantation
and proliferation of circulating cancer cells (Murthy et al, 1991).
Moreover, wounds also promote development oftumours induced
by viruses or oncogenes (Green et al, 1994). Wound-healing and
tumour stroma begin with clotting of plasma proteins (including
fibrinogen, fibronectin and plasminogen) into an insoluble gel that
serves as provisional stroma and is later replaced by granulation
tissue. The recognized differences between the stroma of wounds
and that of tumours can be attributed to the distinct mechanisms
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that initiate each. In wounds, fibrin gel is laid down for only a
limited interval after injury, while continuous generation ofmatrix
occurs in tumours as a result of the constitutive secretion of
vascular endothelial growth factor (VEGF) (Dvorak, 1986).
Fibrinogen, fibrin and related proteins have been implicated in
facilitating tumour cell attachment to the wound site (Murthy et al,
1991). Thus the repair processes involved in wound healing could
contribute to tumour attachment and growth (Dvorak et al, 1987).
Normal wound-healing can be divided into three consecutive
phases: (1) haemostasis and inflammation (days 0-3 after injury);
(2) re-epithelialization and granulation (days 3-14 after injury);
(3) scar tissue remodelling (days 7-30 after injury) (Lynch, 1991;
Moulin, 1995). Granulation includes macrophage accumulation,
fibroblasts ingrowth, matrix deposition and angiogenesis. Many
growth factors are released during tissue repair, and some of them
have been shown to be angiogenic in vivo (Lynch, 1991; Franket al,
1995; Moulin, 1995). The up-regulation of VEGF and its receptor
during woundrepair suggests an important role ofthis growth factor
in wound angiogenesis (Detmar et al, 1995; Frank et al, 1995).
In contrast with the highly regulated transient neovasculariza-
tion during wound-healing, tumour development requires persis-
tent angiogenesis (Folkman and Shing, 1992; Folkman, 1995)
Angiogenesis induces tumour growth not only because of
increased perfusion but also because of the paracrine stimulation
oftumour cells by growth factors and matrix proteins produced by
the new capillary endothelium (Rak et al, 1994). Constitutive
secretion of angiogenic growth factors from tumour cells can
result from a genetic transformation (angiogenic switch) or can be
induced by hypoxic stress (Shweiki et al, 1995; Waleh et al, 1995).
The goal of this study was to evaluate the spatial-temporal
dependence of tumour progression and neovascularization on
tissue injury. Primary vascularization and growth of an implanted
multicellular spheroid were followed using non-invasive magnetic
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Figure 1 Enhancement of tumour growth and inhibition of wound-healing
for C6 glioma spheroids implanted in nude mice. External photographs of
mice taken 18 days after tumour implantation (wound, full arrow; spheroid,
empty arrow). Left mouse: the spheroid was implanted on the site of the
incision. The incision is still visible, 18 days after injury, and tumour volume is
relatively large. Right mouse: the spheroid was implanted 1 cm away from
the incision. Within 7 days, the wound has completely healed and is nearly
undetectable by 18 days, and the tumour size is relatively small
resonance imaging (MRI) (Abramovitch et al, 1995). We found
that proximal incisions induced tumour as well as wound
angiogenesis and inhibited subsequent regression of the wound
vasculature, resulting in faster tumour growth and impaired
A
C
wound-healing. In addition, an injury damaging the tumour vascu-
lature led to accelerated tumourgrowth, which was consistent with
stress-induced vascularization.
MATERIALS AND METHODS
Cell culture and spheroid preparation
C6 rat glioma cells were cultured in Dulbecco's Modified Eagle
Medium (DMEM) supplemented with 5% fetal calf serum (FCS,
Biological Industries Israel), 50 unit ml' penicillin, 50 ,ug ml'
streptomycin and 125 gg ml' fungizone (Biolab). Aggregation of
cells into small spheroids was initiated in agar-coated bacterio-
logical plates. After 4-5 days, the spheroid suspension was trans-
ferred to a spinner flask (Bellco, USA) and the medium changed
every other day for approximately 6 weeks. Other culture condi-
tions were as reported previously (Abramovitch et al, 1995;
Schiffenbauer et al, 1995; Shweiki et al, 1995).
Spheroid implantation in nude mice
Male CD1-nude mice (2 months old, 30 g body weight) were
anaesthetized with 75,g g-' Ketamine + 3,g g-' Xylazine (i.p.)
and placed in a sterile laminar flow hood. A single spheroid per
mouse, 1 mm in diameter, was implanted subcutaneously in the
lower back using a Teflon tubing at different distances from the






Figure 2 Histological analysis of wound-tumour interaction. (A and B) Normal healing of an incision, 2 days (A) and 14 days (B) after injury. Note the clonting
on the surface of the incision on day 2 (arrowheads) and the dense vascularization of the inner skin layers. By the end of the healing process, epithelialization of
the skin surface is complete and a dense fibrotic scar fills the gap formed by the incision (B). (C) Tumour located on an incision 3 weeks after spheroid
implantation. Note the infiltration of the tumour into all layers of the skin and the inhibition of re-epithelialization (white arrowheads). (D) A tumour (T) implanted
more than 1 cm from an incision shows 3 weeks after implantation a significantly less invasive growth. Both tumours show dense vascularization and no
necrosis. Black bars are 1 mm. The position of the incisions is marked by two black arrows
British Journal ofCancer (1998) 77(3), 440-447 . CancerResearch Campaign 1998










Figure 3 Relative vascular density progression for wound-tumour systems.
Apparent vessel density [AVD = - In (AC)] was measured by gradient echo
MRI at different days after tumour implantation for spheroids implanted at
different distances from the incision. Data were obtained in vivo from an
image of a slice of the inner subcutaneous region of the skin, 0.6-1.2 mm
from the surface of the skin (Bruker 4.7 T Biospec, TE 10.5 ms, TR 100 ms,
in plane resolution 110gim, slice thickness 0.5-0.6 mm). (A) AVD
progression around the tumour as a function of distance from the wound.
(B) AVD progression around the wound as a function of distance from the
tumour. Note the elevated vascular density of both the tumour and the
wound, apparent even after 9 days, for a tumour positioned on the incision.
AVD was 2.2-fold higher (t-test, P = 0.013) at 9 days for tumours located on
wounds than that for tumours further than 0.5 mm from the wound. Wounds
more distant to the tumour show a significant regression of blood vessels
5 days after injury
1995). Between 10 and 30 mice were used for each group. The
incision was formed by fine surgical scissors and closed with
cyanoacrylate (SUPER GLUE-3, Loctite, Ireland) or with an adhe-
sive bandage (Tegaderm, USA). Histological sections revealed no
effect ofcyanoacrylate on wound-healing when applied externally,
as also reported previously (Giray et al, 1995). On the other hand,
when cyanoacrylate came in direct contact with tumour cells,
tumour growth was inhibited. Thus, in most experiments the
incisions were closed with the adhesive bandage.
NMR microimaging of the incision and the implanted
spheroid
Nuclear magnetic resonance (NMR) experiments were performed
on a horizontal 4.7 T Bruker-Biospec spectrometer using a 2-cm
surface coil as reported previously (Abramovitch et al, 1995). Mice
were anaesthetized with 75 jg g-' Ketamine + 3 ,ug g-1 Xylazine
(i.p.) and placed supine with the tumour or the incision located at
the centre ofthe surface coil. Gradient echo images were acquired
with a slice thickness of 0.5-0.6 mm, TE of 20 ms, TR of 100 ms
and 256 x 256 pixels matrix, resulting in a resolution of 110 ,um.
Data processing
NMR data were analysed on a Personal Iris work station (Silicon
Graphics, USA) with software from NMRi (TRIPOS). Statistical
significance of treatments was determined using the Student t-test
or ANOVA. Errors reported are the standard deviation. The
distances between the incisions and the spheroids were determined
from the images with a spatial accuracy of 0.2 mm. Growth ofthe
capillary bed was reflected by reduction of the mean intensity at a
region of interest of 1 mm surrounding the spheroid or the inci-
sion. Angiogenic contrast (AC) was previously defined as the ratio
between the mean intensity at a region of interest of 1 mm
surrounding the incision or the spheroid to the mean intensity of a
distant muscle (Abramovitch et al, 1995). Data are reported here as
apparent vessel density (AVD), where AVD = - ln (AC).
A detailed analysis of the effects of blood vessels on image
contrast in gradient echo MRI was given by Ogawa and Lee
(1990). Briefly, blood vessels containing deoxyhaemoglobin lead
to attenuated signal intensity due to shortened T2* relaxation.
The magnitude of signal loss depends on vessel density, blood
oxygenation and the diameter and orientation ofthe vessels. In the
systems described here, the overwhelming change is in the density
of the vasculature. However, in view of the complexity of the
contrast, all AVD values determined by MRI, for each mouse,
were verified by visual examination of the vascularization in the
skins at the end of each experiment. We found, in all cases, a good
correlation between the MRI determined AVD and visual inspec-
tion of vascularization in the skins (Abramovitch et al, 1997). The
functionality of the vasculature contributing to the AVD was veri-
fied in vivo in a number of mice by contrast modulation in mice
breathing alternately 95% air, 5% carbon dioxide or 95% oxygen,
5% carbon dioxide (data not shown).
Histology
Skin with tumour specimens were fixed in neutral buffer formalde-
hyde (pH 7) for 24 h, washed in 70% ethanol, embedded in
paraffin, sectioned and stained with Light green (Masson), eosin
and haematoxylin.
RESULTS
Induced tumour growth and inhibited healing in
wound-tumour systems
The clinical observation of enhanced probability of metastatic
implantation in the site of injury suggests that injury provides a
favourable milieu for the initial stages of tumour growth. To study
this phenomenon, we designed a model system of multicellular
spheroids implanted atdifferentdistances from a4-mm skin incision.
We observed induced tumour growth as well as impaired wound-
healing for all wounds located within 5 mm or less from a tumour,
and these wounds were still externally visible 3 weeks after injury
(Figure 1). Quantitative analysis ofthese phenomena will be reported
in the following sections.
Histological sections of control incisions showed extensive
angiogenesis on the second day after injury (Figure 2A) and
complete re-epithelialization by day 7, leaving a thickened fibrotic
scar 14 days after injury (Figure 2B). Similar kinetics of healing
was observed for incisions located further than 5 mm from a
tumour. On the other hand, wounds located within less than 5 mm
of tumours did not complete re-epithelialization even by 3 weeks,
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Figure 4 MRI gradient echo images of full-thickness dermal incisions in nude mice. Gradient echo images were obtained on a Bruker 4.7 T Biospec
(TE 10.5 ms, TR 100 ms, in plane resolution 110 pim, slice thickness 0.5-0.6 mm). Incisions are marked by white arrows. (A) Upper slice of the outer cell layers
of the skin, 1 day after incision. (B) Second slice of the inner subcutaneous region of the skin, 1 day after incision. Note the darkening of the periphery of the
incision. (C) Second slice of the inner subcutaneous region of the skin, 2 days after incision, spheroid implanted at incision site. (D) Second slice of the inner
subcutaneous region of the skin, 7 days after incision, spheroid implanted at incision site (same mouse as in C). (E) Second slice of the inner subcutaneous
region of the skin, no spheroid, 2 days after incision. Note the darkening of the periphery of the incision. (F) Second slice of the inner subcutaneous region of
the skin, no spheroid, 7 days after incision (same mouse as in E). Note the inhibition of vessel regression and wound-healing in tumour wounds (D) relative to
normal incisions (E and F). Blood clotting is apparent in the first 2 days after injury (C and E, black arrows)
and inflammatory cells were observed between the wound and the
tumour (Figure 2C). The tumours were significantly more invasive
in these cases and infiltrated the dermis (Figure 2C). Tumours
located further than 5 mm from the injury grew to smaller size and
remained encapsulated at 3 weeks after implantation (Figure 2D).
Even when these tumours reached a similar size, they remained
encapsulated and did not invade the dermis or disturb the integrity
ofthe epithelium (data not shown).
Tumour angiogenesis is enhanced by tissue injury
The spatial dependence and temporal kinetics oftumour implantation
were evaluated using MRI. When spheroids were implantedprecisely
at the incision site, the lag in tumour growth was shortened to 2.9 ±
0.2 (n = 3), relative to a 5.15 ± 1.6 (n = 5) day lag observed for spher-
oids implanted 5 mm or more from the incision (Abramovitch et al,
1995). Accordingly, tumour diameter, 3 weeks after implantation,
was 3.78 ± 0.58 mm (n = 8) for spheroids implanted at the site ofthe
incision, relative to 2.16 ± 0.24 mm (n = 6) measured for spheroids
implanted far from the incision (P = 0.0001, Student's t-test). This
correlated with the enhanced vascularization around the spheroid
measured after 2-3 days, which was significantly larger than that
observed forspheroids implantedfurtherthan 5 mmfromthe incision
(Figure 3A). AVD measured by MRI 9 days after implantation was
2.2-fold larger for spheroids implanted on the incision relative to
tumours implanted further away (P = 0.013). Spheroids implanted
5 mm or more from the incision showed no detectable enhancement
in the rate ofvascularization orprogression.

















Figure 5 Growth of vascular tumours can be enhanced by incisions.
Spheroids were implanted 1 cm away from the incision. Second incisions
were made 11 days after implantation at 0.1 and 0.8 cm from the tumour.
Note the enhancement observed in tumour growth as a result of the second
incision in the following specific cases. Immediate acceleration of tumour
growth was observed for tumours located within 5 mm from the injury (0).
More distant injuries (> 0.8 cm) accelerated tumour growth only when the
incision damaged the existing tumor vasculature (A). Distant injuries that did
not perturb tumour vasculature (C) had no effect, and tumours progressed as
in control mice (0).--, 0.1 cm; -A-, 0.8 cm (vessel damage); -{}I-, 0.8 cm,
(no vessel damage); -0-, no second incision
Perturbation of wound angiogenesis in the presence of
a tumour
Wound-healing was followed using gradient echo images obtained
from two consecutive slices of 0.6 mm thickness (Figures 3B and
4). The first slice covered the outer cell layers of the skin,
including the epidermis and part of the dermis (Figure 4A). The
second slice covered the inner cell layers of the skin dermis and
the subcutaneous blood vessels (Figure 4B). The incision was
clearly visible in both slices at the firstday after injury (Figures 4A
and B). Blood clotting was apparent during the first 2 days after
injury, primarily in the first slice but occasionally also in the inner
slice (Figure 4A, C and E). Such clots showed features character-
istic of susceptibility artifacts and complete loss of signal in their
centre (Posse and Aue, 1990). These blood clots disappeared
usually by day 3 after injury and were visually different and distin-
guishable from the gradual darkening of the 1-mm periphery of
angiogenic stimuli (wounds, tumours or beads containing angio-
genic growth factors), which correlated with neovascularization.
Images of the second slice showed initial brightening of the
wound that was most apparent on days 1-2 after surgery and was
related to fluid accumulation associated with inflammation (Figure
4B and E). This was followed by progressive darkening of the
periphery of the incision that correlated with intense neovascular-
ization and was maximal on days 3-4 from injury (Figure 3B,
'infinity'). At later stages of healing, the darkening of the wound
periphery in gradient echo images decreased and, accordingly,
blood vessels disappeared from the scar region. At its maximum,
signal loss around the incision was about twofold larger than that
observed for the steady-state angiogenic contrast around an
implanted C6 rat glioma tumour (Abramovitch et al, 1995). Within
5-6 days, the wound seemed to be fully recovered externally and
there was no detectable contrast around the incision in NMR
images (Figure 3B and 4F). The remaining scar was slightly hyper-
intense relative to the background and was devoid of large blood
vessels.
While healing of a normal incision was completed within 10
days, healing of an incision in the presence of a tumour was
impaired. The spatial geometrical constraints of this effect were
studied on spheroids implanted at different distances from the inci-
sion (Figure 3B). When the spheroid was implanted in the site of
incision, the wound was externally apparent even after 18 days
(Figure 1). For these mice, angiogenic contrast around the incision
did not disappear, and the apparent vessel density (AVD) in the
periphery of the incision remained high (Figures 3B and 4D).
When the spheroid was implanted further than 0.5 cm from the
incision, there was no visible interference with the healing process.
Sham implantation of agarose beads of a similar diameter (1-
5 mm), at different distances from the incision, did not inhibit
wound-healing (n = ten mice; two incisions in each mouse).
Tissue injury induces the progression of vascular
tumours
The induction of tumour growth observed for tumours located
within 5 mm of injury was also apparent when incisions were
applied on already vascularized tumours. In each mouse, a single
tumour was initiated from implanted spheroid as reported previ-
ously (Abramovitch et al, 1995). A 4-mm incision was made
11 days after spheroid implantation. When the incision was very
close to the spheroid (0.1 cm), tumour growth was immediately
enhanced, with no apparent lag (Figure 5). In this case, tumour size
7 days after performing the incision was twofold larger than with
no incision [7.45 ± 0.18 mm3 (n = 2) and 3.57 ± 0.46 mm3 (n = 5)
respectively; P < 0.05, Student's t-test]. Incisions that were further
than 5 mm from the tumour promoted tumour growth only when
they caused partial disruption of the tumour perfusion. In such
cases, enhancement of tumour growth was observed after a lag of
about 5 days (Figure 5), and massive vascularization was observed
on the side of the tumour facing the incision, originally perfused
by vessels damaged by the incision (Figure 6). Tumour-doubling
time, 7 days after the incision, was the same for both proximal and
distant incisions, which disrupted tumour perfusion, and was
threefold higher than for mice with no incision or with an incision
that did not perturb tumour perfusion (95% significance level,
ANOVA) (Figure 5).
DISCUSSION
The increased probability of recurrence and accelerated tumour
growth in the location of the tissue injury are common clinical
complications associated with the invasive procedures frequently
used in cancer therapy, including biopsy and surgery. In the study
reported here, we applied quantitative MRI to follow angiogenesis
and tumour growth in tumour-wound systems of C6 glioma in
nude mice. The assumption that underlies this study is that angio-
genesis is limiting the rate of growth of an implanted avascular
multicellular tumour spheroid and that the bottle neck is the
limited production of angiogenic growth factors rather than a
limited capacity of the host to respond to the angiogenic stimuli.
In such a case, increasing the angiogenic stimulation will also
increase the extent of vascularization and subsequently the initial
rate oftumour growth.
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Figure 6 Tumour neovascularization induced by distant incision. Spheroid (arrow head) was implanted 1 cm away from the incision. A second 4-mm incision
(arrows) was made 9 days (A and B) or 11 days (C and D) after spheroid implantation at 0.8 cm from the tumour. Note the massive vascularization on the left
side of the tumour facing the incision, which damaged the tumour vasculature, in comparison to the other side of the tumour (A and B). Neovascularization
appears as redness in photographs (A) and as darkening in MRI images (B). When the incision did not damage the vasculature, no effect was observed on
tumour neovascularization (C and D) and on tumour growth (Figure 5). (A and C) Skin photographs taken 13 days after the second incision. (B and D) Gradient
echo images of the inner region of the skin from the same mouse obtained 7 days after the second incision. Black bars are 2 mm
Skin injuries are associated with extensive angiogenesis during
the first 3 days of healing and thus could provide an angiogenic
stimulus that will be stimulatory to tumour implantation. In accor-
dance with the supposition laid above, we find that injury in prox-
imity to a tumour invokes an angiogenic activity that is larger than
that provided by either one ofthem alone. These results imply that
the angiogenic capacity of the vascular system is not saturated by
each of these triggers. Moreover, these results suggest that any
genetic transformation or environmental milieu that will increase
the production ofangiogenic stimuli could also increase neovascu-
larization and promote tumour growth.
We have previously demonstrated that after vascularization of
implanted C6 glioma spheroids the expression ofVEGF decreases
to the residual low level of constitutive expression (Shweiki et al,
1995). Correspondingly, we found that the rate of tumour growth
decreases following Gompertz rather than exponential kinetics
(Abramovitch et al, 1995). One possible explanation for these
results is that the rate of tumour progression 1-2 weeks after
spheroid implantation is limited by the reduced expression of
VEGF. By invoking hypoxic stress in the tumour, we would expect
to get a second wave of neovascularization and accelerated
growth. Indeed, when a second distant (> 8 mm) incision was
created 11 days after tumour implantation, damaging vessels irri-
gating the tumour, we observed a latent enhancement of tumour
growth. Such enhancement was not observed in cases in which a
similar incision did not damage vessels irrigating the tumour. This
effect of a distant (> 8 mm) incision on a vascular tumour was
observed after a lag ofapproximately 4-5 days and was associated
with distinct neovascularization of the side of the tumour facing
the incision, which was larger than the vascularization on the other
side ofeither the incision or the tumour. These findings are consis-
tent with the hypothesis that by making the tumourpartly hypoxic,
the levels of stress-induced angiogenic growth factors (such as
VEGF) increase in the tumour, leading to a wave of neovascular-
ization that could support a burst ofregrowth.
Another important issue that appeared in the course of these
experiments was the observation that wounds located on tumours
did not completely heal even after 3 weeks, whereas normally the
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scar would be almost undetectable externally by 7 days. This
observation reproduces a previous report that tumours, regardless
of cell type, inhibit wound-healing (Gatenby and Taylor, 1990).
Such inhibition ofhealing ofthe wound by a tumourcould theoret-
ically imply a continuous release of growth factors from the
wound further stimulating tumour progression, resulting in a
vicious cycle in which accelerated tumour progression is driven by
persistent non-healing wounds.
We report here the obstruction of vascular regression in wounds
located in proximity to tumours. We would like to postulate that, in
normal healing, restoration ofperfusion and normoxia down-regu-
lates the production of angiogenic factors (e.g. VEGF), and this
will lead to vessel regression. Indeed, it was recently shown that
VEGF acts as a survival factor for newly formed capillaries, and
VEGF withdrawal results in vessel regression (Alon et al, 1995).
In the presence of a proximal C6 glioma spheroid, VEGF released
by the spheroid (Shweiki et al, 1995) may be sufficient to confer
survival of the wound vasculature and prevent vessel regression.
Angiogenesis is generally believed to be an essential component of
healing during the first days after injury. In view of the data
presented here, possibly at later stages after injury, vascular regres-
sion is obligatory for completion of the healing, and healing may
be blocked by the persistent neovascularization.
MRI as a tool for studying angiogenesis provides a major
advantage over histology in the ability to monitor a full-time
course non-invasively. The commonly used in vivo assays for
angiogenesis, such as the window chambers, involve massive
injury and limited access to the tumour and thus cannot be used for
monitoring the effects of a defined injury on tumour vasculariza-
tion. Finally, MRI can potentially be applied for clinical assess-
ment oftumour involvement during recovery from surgery.
In summary, we showed here that proximal wounds promote
angiogenesis and growth of avascular tumours. In our model,
which uses small, full-thickness, dermal-incisional wounds, this
mechanism requires close proximity of the injury to the tumour
and was found to be spatially restricted to less than 5 mm. The
spatial restriction of this effect will probably vary between tissues
depending on the rates of diffusion and clearance of the different
mitogens. In addition, wounds damaging the tumour vasculature
promoted tumour growth, even when the distance between the
tumour and the injury was greater than 5 mm, suggesting that such
injuries invoke stress-induced angiogenesis in the tumour. In view
of the elevated angiogenic activity in the wound-tumour systems
and the correlation between impaired healing and inhibition of
vessel regression, it would be interesting to evaluate the effect of
anti-neovascularization therapy, which would, on one hand, inhibit
tumour angiogenesis and, on the other hand, would impose regres-
sion of vessels around the persistent wound. Finally, non-invasive
kinetic MRI analysis of the angiogenic response after dermal inci-
sion provided a unique sensitivity to the accelerated neovascular-
ization associated with the presence of proximal tumours, which
could potentially be induced by the incision, leading to local
tumour recurrence. The diagnostic potential ofMRI in early detec-
tion of tumour involvement in wounds should be evaluated.
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